|Bid||128.21 x 1800|
|Ask||130.68 x 1000|
|Day's Range||128.03 - 130.46|
|52 Week Range||105.32 - 131.60|
|Beta (5Y Monthly)||0.67|
|PE Ratio (TTM)||40.82|
|Earnings Date||Jan 25, 2022 - Jan 31, 2022|
|Forward Dividend & Yield||1.80 (1.39%)|
|Ex-Dividend Date||Oct 14, 2021|
|1y Target Est||132.05|
1 in 2 people don't take their treatment. Abbott is taking action with a:care.
Abbott (ABT) is registering strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.
The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp